Mostrando 2 resultados de: 2
Finerenone: A potential treatment for patients with chronic kidney disease and type 2 diabetes Mellitus
ReviewAbstract: Type 2 diabetes mellitus (T2DM) affects an estimated 463 million people worldwide, equivalent to 1 iPalabras claves:cardiovascular diseases, Chronic kidney disease, Diabetic nephropathies, FinerenoneAutores:D’marco L., Forquet C., Gandía L., Giménez-Civera E., Juan-García I., Panizo N., Puchades M.J., Reque J., Teruel J.L., Valmore BermúdezFuentes:scopusEpicardial adipose tissue, adiponectin and leptin: A potential source of cardiovascular risk in chronic kidney disease
ReviewAbstract: The importance of cardiometabolic factors in the inception and progression of atherosclerotic cardioPalabras claves:adiponectin, Cardiovascular disease, Epicardial adipose tissue, leptinAutores:D’marco L., Lima-Martínez M., Puchades M.J., Raggi P., Romero-Parra M., Soto C., Teruel J.L., Valmore BermúdezFuentes:scopus